Filing Details
- Accession Number:
- 0001415889-24-014661
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-28 16:22:40
- Reporting Period:
- 2024-05-23
- Accepted Time:
- 2024-05-28 16:22:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1258693 | Grant Pickering | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-05-23 | 15,000 | $2.03 | 492,847 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-05-23 | 6,211 | $68.84 | 486,636 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-05-23 | 8,789 | $69.84 | 477,847 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2024-05-23 | 15,000 | $0.00 | 15,000 | $2.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
212,327 | 2028-07-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 146,054 | Indirect | By Children's Trust |
Common Stock | 146,054 | Indirect | By Children's Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $68.32 to $69.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $69.56 to $71.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- Shares are held directly by a trust for the benefit of the Reporting Person's son.
- Stock Option is fully vested and exercisable.